- Home
- LOCO vs CERS Comparison
LOCO vs CERS Comparison
Compare LOCO & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOCO
- CERS
- Stock Information
- Founded
- LOCO 1980
- CERS 1991
- Country
- LOCO United States
- CERS United States
- Employees
- LOCO N/A
- CERS N/A
- Industry
- LOCO Restaurants
- CERS EDP Services
- Sector
- LOCO Consumer Discretionary
- CERS Technology
- Exchange
- LOCO Nasdaq
- CERS Nasdaq
- Market Cap
- LOCO 323.7M
- CERS 276.0M
- IPO Year
- LOCO 2014
- CERS 1997
- Fundamental
- Price
- LOCO $10.53
- CERS $1.45
- Analyst Decision
- LOCO Buy
- CERS Buy
- Analyst Count
- LOCO 2
- CERS 1
- Target Price
- LOCO $18.00
- CERS $4.00
- AVG Volume (30 Days)
- LOCO 338.7K
- CERS 1.1M
- Earning Date
- LOCO 10-30-2025
- CERS 11-06-2025
- Dividend Yield
- LOCO N/A
- CERS N/A
- EPS Growth
- LOCO 13.62
- CERS N/A
- EPS
- LOCO 0.89
- CERS N/A
- Revenue
- LOCO $480,815,000.00
- CERS $192,510,000.00
- Revenue This Year
- LOCO $6.13
- CERS $19.07
- Revenue Next Year
- LOCO $1.56
- CERS $12.03
- P/E Ratio
- LOCO $11.81
- CERS N/A
- Revenue Growth
- LOCO 2.09
- CERS 13.25
- 52 Week Low
- LOCO $8.29
- CERS $1.12
- 52 Week High
- LOCO $13.24
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- LOCO 64.09
- CERS 46.04
- Support Level
- LOCO $8.99
- CERS $1.48
- Resistance Level
- LOCO $10.83
- CERS $1.54
- Average True Range (ATR)
- LOCO 0.38
- CERS 0.08
- MACD
- LOCO 0.14
- CERS -0.02
- Stochastic Oscillator
- LOCO 83.74
- CERS 17.86
About LOCO El Pollo Loco Holdings Inc.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. Restaurant locations are typically free-standing and include drive-thrus, and menus include many low-priced options. Poultry is the company's largest food cost, accounting for roughly 38% of total food and paper cost, and the company manages that commodity price risk by using multiple suppliers and entering supply contracts of varying lengths depending on market conditions.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.